Outcome of Board Meeting-Unaudited Result for the quarter and half year ended on 30th September, 2026.

Our Ref. No. : BSE/LODR/2026/0595 Date : 28th October, 2026 Corporate Relationship Department, BSE Limited, 14th Floor, P.J. Towers, Dalal Street, Fort, Mumbai – 400 001 BSE Equity Scrip Code : 530665 Dear Sirs, SUB : Outcome of Board Meeting This is to inform you under Regulation 30 and any other Regulation of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 that the meeting of the Board of Directors of the Company was held on Wednesday, 28th October, 2026 at the registered office of the company and the said meeting commenced at 3:45 P.M. and concluded at 4.25 P.M. In that meeting the Board has approved the following matters: 1. Considered and approved the un-audited Financial Result of the Company for the quarter and half year ended on 30th September, 2026 along with Limited Review Report as issued by the statutory auditor of the Company. Copy of the same is enclosed herewith;. Kindly acknowledge the same & oblige. Thanking you, For Zenith Healthcare Limited (Mahendra Raycha) Chairman & Managing Director DIN : 00577647 ZENITH HEALTHCARE LIMITED CIN : L24231GJ1994PLC023574 Reg Office :- 504, Iscon Elegance, Prahlad Nagar Cross Road Nr. Anand Dham Jain Derasar, S. G. Road, Ahmedabad, Gujarat, India, 380051. Tel No. 079-66168889, Email id :- mahendrazenith@hotmail.com STATEMENT OF FINANCIAL RESULTS FOR THE QUARTER AND HALF YEAR ENDED 30th SEPTEMBER, 2026 (Rs. In Lakhs Except EPS) SR.NO. PARTICULARS. Quarters Ended on Half Year Ended on Year ended on 30.09.2026 30.06.2026 30.09.2025 30.09.2026 30.09.2025 31.03.2026 (UNAUDITED) (UNAUDITED) (UNAUDITED) (UNAUDITED) (UNAUDITED) (AUDITED) INCOMES I Revenue from Operations 201.14 343.27 226.66 544.41 5 41.77 1 ,052.22 II Other Income 12.36 6.86 1 0.91 1 9.22 27.49 4 1.44 III Total Income (I + II) 213.50 3 50.13 2 37.57 5 63.63 569.26 1 ,093.65 IV EXPENSES. (a) Cost of materials consumed 75.01 9 7.46 7 3.27 172.47 1 84.57 428.71 (b) Purchase of Stock in Trade. 5.67 0.29 2.26 5.96 7 .85 6 8.52 (c) Changes of Inventories of Finished Goods, 1.92 6 0.21 ( 4.27) 6 2.13 38.51 ( 13.08) Work in Progress, Stock in Trade. ( d) Employee benefits expense 40.36 4 9.69 4 0.31 9 0.05 81.76 180.23 (e) Finance Cost 0.05 0.14 0.11 0.19 0 .50 0.87 (f) Depreciation and Amortisation Expenses 5.12 6.15 6.52 1 1.27 12.60 2 5.84 (g) Other Expenses 84.13 118.06 9 7.51 202.19 2 24.23 400.97 TOTAL EXPENSES IV (a to g) 212.27 3 32.00 2 15.71 5 44.27 550.02 1 ,092.05 V Profit/(Loss) before Exceptional Items and 1 .23 1 8.13 2 1.86 1 9.36 1 9.24 1.60 Tax. (III-IV) VI Exceptional Items. & Extraordinary Item VII Profit/ (Loss) Before Tax. (V-VI) 1 .23 1 8.13 2 1.86 1 9.36 1 9.24 1.60 VIII TAX EXPENSES. (a) Current Tax. -0.06 5.27 5.10 5.21 5 .10 1.13 (b) Deffered Tax. -1.07 ( 0.76) 2.58 ( 1.83) 1 .85 ( 2.44) (c) Earlier year tax adjustments - - - - 2.39 Total Tax Expenses. ( 1.14) 4.51 7.68 3.37 6 .95 1.09 IX NET PROFIT / (LOSS) FOR THE PERIOD 2 .37 1 3.62 1 4.18 1 5.99 1 2.29 0.51 X Items that will not be reclassified to profit or loss (i) Re-measurement gains on defined benefit plans - - - - - 1.72 (ii) Income tax relating to items that will not be reclassified to profit or loss - - - - - ( 0.43) Other comprehensive income for the year, net of tax - - - - - 1.29 Total comprehensive income for the Period/year 2 .37 1 3.62 1 4.18 1 5.99 1 2.29 1.80 XI Total Income for the year (IX-X) 2 .37 1 3.62 1 4.18 1 5.99 1 2.29 1.80 XII Paid up Equity Share Capital (Amount in lacs) 537.39 5 37.39 5 37.39 5 37.39 537.39 5 37.39 Rs. 1 Face value per share) Rs. 1/- Rs. 1/- Rs. 1/- Rs. 1/- Rs. 1/- Rs. 1/- XIII Other Equity excluding revaluation reserves as per balance sheet - 205.03 XIV Earning Per Share (In Rupees) (i) Basic. 0 .004 0.025 0.026 0.030 0 .023 0.003 (ii) Diluted. 0.004 0.025 0.026 0.030 0 .023 0.003 NOTES: 1 These financial result were reviewed by the Board of Directors and thereafter have been approved by the board of directors at its meeting held on Wednesday, October 28, 2026. The Statutory Auditors have carried out limited review of the financial result for the Quarter and Half year ended on September 30, 2026. 2 Financial results for all the periods presented have been prepared in accordance with the Companies (Indian Accounting Standards) Rules, 2021 (as amended from time to time) prescribed under Section 133 of the Companies Act, 2013 and other recognised accounting practices and policies to the extent applicable and in compliance with Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, as amended. 3 Company has only one reportable segment - Pharmaceuticals Business as per requirement of Ind AS 108. 4 On July 14, 2026, the Board approved a Scheme of Amalgamation of Achyut Healthcare Limited with and into the Company under Sections 230 to 232 of the Companies Act, 2013, with a share exchange ratio of 119 equity shares of the Company for every 50 equity shares of Achyut Healthcare Limited, both of face value of 1 each. The Scheme is subject to approval from BSE, shareholders and creditors, the NCLT and other authorities. Accordingly, no effect of the Scheme has been given in these results. 5 Figures for the previous period have been regrouped/ rearranged/ reclassfied wherever considered necessary to correspond with the current period's classification/group's disclosure. For, Zenith Healthcare Limited Mahendra C. Raycha Chairman & Managing Director DIN : 00577647 Dated : 28th October 2026 Place : Ahmedabad ZENITH HEALTHCARE LIMITED CIN : L24231GJ1994PLC023574 Reg Office :- 504, Iscon Elegance, Prahlad Nagar Cross Road Nr. Anand Dham Jain Derasar, S. G. Road, Ahmedabad, Gujarat, India, 380051. Tel No. 079-66168889, Email id :- mahendrazenith@hotmail.com STATEMENT OF ASSETS AND LIABILITIES AS AT 30th SEPTEMBER, 2026 (Rs. In Lakhs) PARTICULARS. AS AT 30 September 2026 AS AT 31 March 2026 UNAUDITED AUDITED ASSETS. Non-current assets Property, plant and equipment - Tangible assets 154.62 1 45.27 - Intangible assets 0.09 0 .09 Financial Assets: - Investments 1.44 1 .44 - Loans and Advances - - - Others 235.46 206.56 Deferred Tax Assets 1 .91 0 .07 Sub-total- Non Current Assets 3 93.52 353.43 Current assets Inventories 1 86.72 292.34 Financial Assets: - Trade Receivables 304.98 209.18 - Cash and cash equivalents 44.18 3 6.95 - Bank Balance other than above - 0 .08 -Others - 3 3.16 Current tax assets (Net) 2 .32 5 .60 Other current assets 1 62.23 167.84 Sub-total- Current Assets 7 00.43 745.16 TOTAL 1,093.94 1,098.59 EQUITY AND LIABILITIES. Equity Equity share capital 537.39 537.39 Other Equity 221.02 205.03 Sub-total- Shareholder's funds 7 58.41 742.42 NON CURRENT LIABILITIES. Deferred Tax Liabilities. - - Sub-total- Non Current Liabilities - - CURRENT LIABILITIES. Financial Liabilities Trade payables - Total outstanding dues of micro and small enterprises 2.45 5 .20 - Total outstanding dues of creditors other than micro and small enterprises 107.79 147.37 Contract liabilities 2 08.53 194.84 Short Term Provisions 1 .71 2 .84 Other Current Liabilities 1 5.05 5 .92 Sub-total-Current Liabilities 3 35.53 356.17 TOTAL 1,093.94 1,098.59 For, Zenith Healthcare Limited Mahendra C. Raycha Chairman & Managing Director DIN : 00577647 Dated : 28th October 2026 Place : Ahmedabad ZENITH HEALTHCARE LIMITED CIN : L24231GJ1994PLC023574 Reg Office :- 504, Iscon Elegance, Prahlad Nagar Cross Road Nr. Anand Dham Jain Derasar, S. G. Road, Ahmedabad, Gujarat, India, 380051. Tel No. 079-66168889, Email id :- mahendrazenith@hotmail.com CASH FLOW STATEMENT FOR THE YEAR ENDED 30th SEPTEMBER, 2026 (Rs.In Lakhs) For the period ended 30 For the year ended 31 Particulars September 2026 March 2026 A. CASH FLOW FROM OPERATING ACTIVITIES Profit before tax 19.36 1 .60 Depreciation and amortisation expense 11.27 25.84 Interest Expense 0 .19 0 .87 Remeasurement Gain/ (Loss) for Gratuity - 1 .29 Investment classified at fair value through profit or loss - ( 1.22) Interest Income on fixed deposits with banks (2 [Showing first 8,000 characters — download PDF for full document]